Clinical Trials Directory

Trials / Completed

CompletedNCT01216852

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

A Single Dose, 2-Period, 2-Treatment Bioequivalency Study of Losartan Potassium Tablets 100 mg Under Fasted Conditions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Roxane Laboratories · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to prove the bioequivalence of Losartan Potassium 100 tablet under fasted conditions.

Conditions

Interventions

TypeNameDescription
DRUGLosartan Potassium100 mg tablet

Timeline

Start date
2004-08-01
Primary completion
2004-08-01
Completion
2004-08-01
First posted
2010-10-07
Last updated
2018-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01216852. Inclusion in this directory is not an endorsement.